The Review Score Gap
the NewSelf program carries two very different public review scores: a 4.5/5 Excellent Trustpilot rating alongside a 2.7/5 user score from 12 independent reviews collected by AllyRx. This 65% gap is worth examining carefully before enrolling.
| Review Source | Score | Sample Size | Methodology |
|---|---|---|---|
| Trustpilot | 4.5/5 Excellent | Multiple (not disclosed) | Verified purchase reviews |
| AllyRx User Reviews | 2.7/5 | 12 reviews | Independent collection, small n |
| AllyRx Editorial | 68/100 | Structured audit | Multi-criteria editorial scoring |
⚡ Limited Time: Free Overnight Shipping
NewSelf has a 4.5 Trustpilot Excellent rating. Start your free clinical visit today — full refund if your doctor declines.
✓ All dosages same price · ✓ Full refund if declined · ✓ No membership fees
What Positive Trustpilot Reviewers Report
- Fast delivery — medication arrives within 5–7 days of signup
- Helpful clinical support staff and responsive nursing team
- Weight loss consistent with GLP-1 clinical expectations
- Cold chain maintained on delivery — medications arrived properly cold
- Provider review completed same-day or next-day
What Negative Reviewers Report
- Difficulty cancelling after enrollment — persistent billing after cancellation requests
- Unexpected charges — billing after cancellation request was submitted
- Lack of personalized physician engagement (asynchronous-only review)
- Pricing discrepancy — charged at a different rate than the landing page advertised
Our Assessment of the Discrepancy
The Trustpilot 4.5 rating likely reflects primarily patients who successfully completed their program without encountering cancellation or billing difficulties — the majority of positive experiences. The 2.7/5 AllyRx score appears to disproportionately capture patients whose issues centered on the cancellation and billing process. The AllyRx sample of 12 is small; the Trustpilot sample is likely larger but methodologically constrained by platform. Both data points are valid signals from different populations. The safest interpretation: NewSelf's GLP-1 platform delivers for most patients who commit to and complete the program, with notable failure points around cancellation.